- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 5/30 - Oestrogens
Patent holdings for IPC class A61P 5/30
Total number of patents in this class: 188
10-year publication summary
|
2
|
8
|
12
|
14
|
13
|
10
|
11
|
11
|
6
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Recurium IP Holdings, LLC | 131 |
6 |
| Wyeth | 285 |
5 |
| Millicent Pharma Limited | 20 |
5 |
| Estetra SRL | 105 |
5 |
| Wyeth LLC | 642 |
3 |
| Bayer Intellectual Property GmbH | 2439 |
3 |
| Bayer Schering Pharma AG | 355 |
3 |
| Daicel Corporation | 2426 |
3 |
| Estetra S.P.R.L. | 12 |
3 |
| Kobayashi Pharmaceutical Co., Ltd. | 778 |
3 |
| TherapeuticsMD, Inc. | 111 |
3 |
| Insigna, Inc., DBA Epivara | 16 |
3 |
| Mother & Child Co., Ltd. | 5 |
3 |
| Glaxosmithkline Intellectual Property Development Limited | 767 |
2 |
| Kao Corporation | 5028 |
2 |
| National Institute of Advanced Industrial Science and Technology | 3800 |
2 |
| Bionovo, Inc. | 23 |
2 |
| Concordia University, Inc. | 9 |
2 |
| Daré BioScience, Inc. | 37 |
2 |
| DrugTech Corporation | 21 |
2 |
| Other owners | 126 |